{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:49:03Z","timestamp":1789202943785,"version":"build-2803163510"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Vascular calcification (VC) is an independent risk factor for cardiovascular diseases. VC increases mortality of all-causes. VC is one of most common cardiovascular complications in type II diabetes. So far, no therapy has been proven to be effective in treatment of clinical VC. The present study investigated the therapeutic effects of MR409, an agonistic analog of growth hormone-releasing hormone (GHRH-A), on VC in diabetic db\/db mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method and result<\/jats:title><jats:p>Diabetic mice were injected with MR409 subcutaneously every day for 8 weeks. Long-term treatment with MR409 improved serum lipid profile and endothelium-dependent relaxation to acetylcholine, and reduced vascular structural injury in diabetic mice without affecting serum growth hormone level. Echocardiography showed that calcium plaques present in heart valve of diabetic mice disappeared in diabetic mice after treatment with MR409. MR409 inhibited vascular calcium deposition associated with a marked reduction in the expressions of osteogenic-regulated alkaline phosphatase (ALP) and transcription osteogenic marker gene Runx2 in diabetic mice. MR409 also inhibited vascular reactive oxygen species (ROS) generation and upregulated the expressions of anti-calcifying protein Klotho in diabetic mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Our results demonstrate that GHRH-A MR409 can effectively attenuate VC and heart valve calcification, and protect against endothelial dysfunction and vascular injury in diabetic mice without significantly affecting pituitary-growth hormone axis. The mechanisms may involve upregulation of anti-calcifying protein Klotho and reduction in vascular ROS and the expression of redox sensitive osteogenic genes Runx2 and ALP. GHRH-A may represent a new pharmacological strategy for treatment of VC and diabetics associated cardiovascular complications.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2023.1102525","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T04:51:39Z","timestamp":1674017499000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Growth hormone-releasing hormone agonist attenuates vascular calcification in diabetic db\/db mice"],"prefix":"10.3389","volume":"10","author":[{"given":"Hao-Lin","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiping","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruize","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RenZhi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew V.","family":"Schally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Sheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,18]]},"reference":[{"key":"B1","article-title":"Vascular calcification-new insights into its mechanism.","volume":"2020","author":"Lee","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1161\/ATVBAHA.116.306258","article-title":"Arterial calcification in diabetes mellitus: preclinical models and translational implications.","volume":"37","author":"Stabley","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B3","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jacc.2021.06.049","article-title":"Medial arterial calcification: JACC state-of-the-art review.","volume":"78","author":"Lanzer","year":"2021","journal-title":"J Am Coll Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1093\/eurheartj\/ehu163","article-title":"Medial vascular calcification revisited: review and perspectives.","volume":"35","author":"Lanzer","year":"2014","journal-title":"Eur Heart J."},{"key":"B5","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.107.743161","article-title":"Vascular calcification: pathobiology of a multifaceted disease.","volume":"117","author":"Demer","year":"2008","journal-title":"Circulation."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/biology11030414","article-title":"Cardiac calcifications: phenotypes, mechanisms, clinical and prognostic implications.","volume":"2022","author":"Vieceli Dalla Sega","year":"2022","journal-title":"Biology."},{"key":"B7","first-page":"343","article-title":"Mechanisms of ectopic calcification: implications for diabetic vasculopathy.","volume":"5","author":"Avogaro","year":"2015","journal-title":"Cardiovasc Diagn Ther."},{"key":"B8","article-title":"New therapeutics targeting arterial media calcification: friend or foe for bone mineralization?","volume":"2022","author":"Van den Branden","year":"2022","journal-title":"Metabolites."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2016.00129","article-title":"Growth hormone-releasing hormone in diabetes.","volume":"7","author":"Fridlyand","year":"2016","journal-title":"Front Endocrinol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"13651","DOI":"10.1073\/pnas.1518540112","article-title":"Beneficial effects of growth hormone-releasing hormone agonists on rat INS-1 cells and on streptozotocin-induced NOD\/SCID mice.","volume":"112","author":"Zhang","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B11","doi-asserted-by":"publisher","first-page":"13248","DOI":"10.1073\/pnas.1718592114","article-title":"Protective effects of agonists of growth hormone-releasing hormone (GHRH) in early experimental diabetic retinopathy.","volume":"114","author":"Thounaojam","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109600118","article-title":"Agonistic analog of growth hormone-releasing hormone promotes neurofunctional recovery and neural regeneration in ischemic stroke.","volume":"2021","author":"Liu","year":"2021","journal-title":"Proc Natl Acad Sci USA."},{"key":"B13","doi-asserted-by":"publisher","first-page":"8197","DOI":"10.1002\/jcp.30490","article-title":"Improvement of cardiac and systemic function in old mice by agonist of growth hormone-releasing hormone.","volume":"236","author":"Xiang","year":"2021","journal-title":"J Cell Physiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.peptides.2013.12.010","article-title":"Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities.","volume":"52","author":"Cai","year":"2014","journal-title":"Peptides."},{"key":"B15","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1210\/en.2019-00111","article-title":"Actions and potential therapeutic applications of growth hormone-releasing hormone agonists.","volume":"160","author":"Schally","year":"2019","journal-title":"Endocrinology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1073\/pnas.1119203109","article-title":"Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI).","volume":"109","author":"Kanashiro-Takeuchi","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvac098","article-title":"Synthetic growth hormone-releasing hormone agonist ameliorates the myocardial pathophysiology characteristic of HFpEF.","author":"Dulce","year":"2022","journal-title":"Cardiovasc Res."},{"key":"B18","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/CIRCRESAHA.117.312418","article-title":"Regulation of vascular calcification by growth hormone-releasing hormone and its agonists.","volume":"122","author":"Shen","year":"2018","journal-title":"Circ Res."},{"key":"B19","article-title":"Regulatory role of sex hormones in cardiovascular calcification.","volume":"2021","author":"Woodward","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B20","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1161\/CIRCRESAHA.110.236596","article-title":"Activation of vascular bone morphogenetic protein signaling in diabetes mellitus.","volume":"108","author":"Bostrom","year":"2011","journal-title":"Circ Res."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.879693","article-title":"Myeloid angiotensin II type 1 receptor mediates macrophage polarization and promotes vascular injury in DOCA\/salt hypertensive mice.","volume":"13","author":"Yang","year":"2022","journal-title":"Front Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/cvr\/cvw205","article-title":"Runx2 deletion in smooth muscle cells inhibits vascular osteochondrogenesis and calcification but not atherosclerotic lesion formation.","volume":"112","author":"Lin","year":"2016","journal-title":"Cardiovasc Res."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/nu14102124","article-title":"Alkaline phosphatase: an old friend as treatment target for cardiovascular and mineral bone disorders in chronic kidney disease.","volume":"2022","author":"Haarhaus","year":"2022","journal-title":"Nutrients."},{"key":"B24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1681\/ASN.2009121311","article-title":"Klotho deficiency causes vascular calcification in chronic kidney disease.","volume":"22","author":"Hu","year":"2011","journal-title":"J Am Soc Nephrol."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2022.931331","article-title":"Pathobiology of the Klotho antiaging protein and therapeutic considerations.","volume":"3","author":"Prud\u2019homme","year":"2022","journal-title":"Front Aging."},{"key":"B26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bone.2016.11.012","article-title":"Vascular calcification in CKD-MBD: roles for phosphate, FGF23, and klotho.","volume":"100","author":"Yamada","year":"2017","journal-title":"Bone."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1161\/ATVBAHA.120.313131","article-title":"Arterial stiffness: a focus on vascular calcification and its link to bone mineralization.","volume":"40","author":"Chen","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.121.013762","article-title":"Favorable cardiovascular health is associated with lower prevalence, incidence, extent, and progression of extracoronary calcification: MESA.","volume":"15","author":"Ogunmoroti","year":"2022","journal-title":"Circ Cardiovasc Imaging."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.636403","article-title":"The complex world of regulation of pituitary growth hormone secretion: the role of ghrelin, klotho, and nesfatins in it.","volume":"12","author":"Devesa","year":"2021","journal-title":"Front Endocrinol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104861","article-title":"Diabetes and calcification: the potential role of anti-diabetic drugs on vascular calcification regression.","volume":"158","author":"Ghosh","year":"2020","journal-title":"Pharmacol Res."},{"key":"B31","article-title":"Regulation of vascular calcification by reactive oxygen species.","volume":"2020","author":"Toth","year":"2020","journal-title":"Antioxidants."},{"key":"B32","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/CIRCRESAHA.119.316159","article-title":"Reactive oxygen-forming nox5 links vascular smooth muscle cell phenotypic switching and extracellular vesicle-mediated vascular calcification.","volume":"127","author":"Furmanik","year":"2020","journal-title":"Circ Res."},{"key":"B33","article-title":"Loss of PARP-1 attenuates diabetic arteriosclerotic calcification via stat1\/runx2 axis.","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1172\/JCI150051","article-title":"SIRT6 protects vascular smooth muscle cells from osteogenic transdifferentiation via runx2 in chronic kidney disease.","volume":"2022","author":"Li","year":"2022","journal-title":"J Clin Invest."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.112301","article-title":"Indoxyl sulfate promotes osteogenic differentiation of vascular smooth muscle cells by miR-155-5p-dependent downregulation of matrix Gla protein via ROS\/NF-kappaB signaling.","volume":"397","author":"He","year":"2020","journal-title":"Exp Cell Res."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2018.00172","article-title":"Lipoproteins in cardiovascular calcification: potential targets and challenges.","volume":"5","author":"Tintut","year":"2018","journal-title":"Front Cardiovasc Med."},{"key":"B37","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2020.9252","article-title":"Roles of klotho and stem cells in mediating vascular calcification (review).","volume":"20","author":"Yu","year":"2020","journal-title":"Exp Ther Med."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.7095","article-title":"Soluble klotho is decreased in children with type 1 diabetes and correlated with metabolic control.","volume":"12","author":"Zubkiewicz-Kucharska","year":"2021","journal-title":"Front Endocrinol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1102525\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T04:51:53Z","timestamp":1674017513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1102525\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":38,"alternative-id":["10.3389\/fcvm.2023.1102525"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1102525","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,18]]},"article-number":"1102525"}}